Sienna Biopharmaceuticals Inc (SNNAQ)
0.00
USD |
OTCM |
May 24, 16:00
Sienna Biopharmaceuticals Total Assets (Quarterly): 43.49M for Sept. 30, 2019
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 43.49M |
| June 30, 2019 | 107.62M |
| March 31, 2019 | 115.05M |
| December 31, 2018 | 107.31M |
| September 30, 2018 | 124.63M |
| June 30, 2018 | 135.72M |
| Date | Value |
|---|---|
| March 31, 2018 | 123.54M |
| December 31, 2017 | 136.85M |
| September 30, 2017 | 149.45M |
| June 30, 2017 | 92.00M |
| March 31, 2017 | 61.46M |
| December 31, 2016 | 62.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
43.49M
Minimum
Sep 2019
107.62M
Maximum
Jun 2019
75.56M
Average
75.56M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.39M |
| Shareholders Equity (Quarterly) | 23.10M |